Metastatic Renal Cell Carcinoma
Metastatic renal cell carcinoma (mRCC) is a form of kidney cancer that has spread beyond the kidney to other organs, often leading to serious health issues. It can cause various symptoms depending on where it spreads.
Clear Cell Renal Cell Carcinoma: PET Scan Comparison
We are comparing two different PET scans to see which one detects tumors better in patients with clear cell renal cell carcinoma. This study may help improve diagnosis for those suspected of having this type of cancer.
≤3 months≤5 visitsConfirmation phase (III)No PlaceboInvestigational MedicinesInjectionInternal MedicineOncology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have clear cell renal cell carcinoma (ccRCC) that has spread?
- Have you had any kidney problems, such as a GFR of 45 or lower?
- Are you currently pregnant or breastfeeding?
- Have you taken any tyrosine kinase inhibitors in the last month?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Girentuximab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Stichting Radboud universitair medisch centrum
Urology
Nijmegen, Netherlands
Sponsor: Stichting Radboud universitair medisch centrum
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.